![Colleen Sjogren](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Colleen Sjogren
Corporate Officer/Principal chez
NUVATION BIO INC.
Fortune : 559 440 $ au 31/08/2026
Profil
Ms. Colleen Sjogren is a Chief Commercial Officer at Nuvation Bio, Inc. Ms. Sjogren was previously employed as a Senior Vice President-Sales by Madrigal Pharmaceuticals, Inc., a VP-US Sales, Sales Training & Meeting Planning by Mirati Therapeutics, Inc., and a Vice President-National Cell Therapy & Sales by Kite Pharma, Inc. She received her undergraduate degree from Bryant University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/02/2026 | 84 000 ( 0,02% ) | 559 440 $ | 31/08/2026 |
Postes actifs de Colleen Sjogren
| Sociétés | Poste | Début |
|---|---|---|
| NUVATION BIO INC. | Corporate Officer/Principal | 28/03/2024 |
Anciens postes connus de Colleen Sjogren
| Sociétés | Poste | Fin |
|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. | Sales & Marketing | 01/12/2023 |
| MIRATI THERAPEUTICS | Sales & Marketing | 01/09/2022 |
| KITE PHARMA INC | Sales & Marketing | 01/04/2021 |
Formation de Colleen Sjogren
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
69
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Bryant University
 Bryant University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Madrigal Pharmaceuticals, Inc.
 Madrigal Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs for cardiovascular, metabolic and liver diseases | Health Technology |
Nuvation Bio, Inc.
 Nuvation Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops oncology related novel therapeutic candidates | Health Technology |
